Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compound

scientific article

Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compound is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2362.2009.02105.X
P698PubMed publication ID19309323

P2093author name stringJ Buckley
R Paschke
B Jansen
E Selzer
J Thalhammer
K Nagy
M Willmann
T Triche
V Wacheck
P2860cites workHuman ACAT-1 and ACAT-2 inhibitory activities of pentacyclic triterpenes from the leaves of Lycopus lucidus TURCZ.Q40319859
Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9.Q40636708
Establishment of two dog mastocytoma cell lines in continuous cultureQ42810486
P433issue5
P304page(s)384-394
P577publication date2009-05-01
P1433published inEuropean Journal of Clinical InvestigationQ15745208
P1476titleCharacterization of NVX-207, a novel betulinic acid-derived anti-cancer compound
P478volume39